Matthias Dollinger

Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma – The SHELTER study

Michael Bitzer, Marius Horger, Edoardo G. Giannini et al. · Journal of Hepatology · 2016 · 138 citations

Medicine, Oncology, Pharmacotherapy +9

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme

Markus Moehler, Annett Maderer, C Schimanski et al. · European Journal of Cancer · 2014 · 135 citations · Full text

Medicine, Oncology, Pharmacology +11

Human Bone Marrow Mesenchymal Stem Cell-Derived Hepatocytes Improve the Mouse Liver after Acute Acetaminophen Intoxication by Preventing Progress of Injury

Peggy Stock, S Brückner, Sandra Winkler et al. · International Journal of Molecular Sciences · 2014 · 70 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus (HBV) Infection: The German Guidelines for the Management of HBV Infection

Markus Cornberg, Ulrike Protzer, Matthias Dollinger et al. · Zeitschrift für Gastroenterologie · 2007 · 67 citations

Medicine, Infectious Diseases, Pathology +16

Cardiac volume overload and pulmonary hypertension in long‐term follow‐up of patients with a transjugular intrahepatic portosystemic shunt

Andreas Wannhoff, Theresa Hippchen, Cathérine Weiss et al. · Alimentary Pharmacology & Therapeutics · 2016 · 51 citations · Full text

Medicine, Cardiology, Surgery +15